Email from Sanofi: Please note that, starting 2025, Sanofi will be the Commercial lead for Nuvaxovid covid vaccine in Canada. We are working diligently to accelerate this transition process, at this point, we will not be bringing in Nuvaxovid in the private market for the 2025 season.